| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/28/2013 | US20130053308 4-AMINOPYRIMIDINE DERIVATIVES AND THEIR AS AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 02/28/2013 | US20130053304 Glucagon-like peptide-1 analogues and uses thereof |
| 02/28/2013 | US20130053303 Compounds for enzyme inhibition |
| 02/28/2013 | US20130052280 Use of thebromine for lowering central blood pressure |
| 02/28/2013 | US20130052279 Reverse micelle system comprising metal ions and use thereof |
| 02/28/2013 | US20130052270 Use of Gold Nanoclusters in Ameliorating Oxidate Stress and/or Aging |
| 02/28/2013 | US20130052267 Methods of Inducing Tissue Regeneration |
| 02/28/2013 | US20130052266 TABLETS CONTAINING A 1-(beta-D-GLUCOPYRANOSYL)-3-(PHENYLTHIENYLMETHYL)BENZENE COMPOUND |
| 02/28/2013 | US20130052232 Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking |
| 02/28/2013 | US20130052231 Treatment methods utilizing stem cell mobilizers and immunosuppressive agents |
| 02/28/2013 | US20130052213 Novel immunomodulatory peptide |
| 02/28/2013 | US20130052203 In vivo screening models for treatment of qc-related disorders |
| 02/28/2013 | US20130052192 Activatable Constructs |
| 02/28/2013 | US20130052191 Anti-alpha2 integrin antibodies and their uses |
| 02/28/2013 | US20130052185 Yeast hydrolysate having obesity treatment effects and antioxidant activity |
| 02/28/2013 | US20130052184 Gelatinase inhibitors and prodrugs |
| 02/28/2013 | US20130052172 Methods for diagnosing and treating cardiac defects |
| 02/28/2013 | US20130052170 Grafting material for genetic and cell therapy |
| 02/28/2013 | US20130052169 Stem cell bank for personalized medicine |
| 02/28/2013 | US20130052167 Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content |
| 02/28/2013 | US20130052166 Materials and methods for minimally-invasive administration of a cell-containing flowable composition |
| 02/28/2013 | US20130052165 Methods of Producing Adenovirus Vectors and Viral Preparations Generated Thereby |
| 02/28/2013 | US20130052162 Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon |
| 02/28/2013 | US20130052155 Compositions and Methods for Treating a Disorder or Defect in Soft Tissue |
| 02/28/2013 | CA2846251A1 Anti-vcam-1 nanobodies |
| 02/28/2013 | CA2845093A1 2 -amino-4 - (pyridin- 2 -yl) - 5, 6 -dihydro-4h- 1, 3 -oxazine derivatives and their use as bace-1 and/or bace - 2 inhibitors |
| 02/27/2013 | EP2561883A2 Novel vascular endothelial growth factor expression inhibitors |
| 02/27/2013 | EP2561882A2 Novel vascular endothelial growth factor expression inhibitors |
| 02/27/2013 | EP2561881A2 Novel vascular endothelial growth factor expression inhibitors |
| 02/27/2013 | EP2561874A2 Pharmaceutical compositions for treating cancer |
| 02/27/2013 | EP2560962A1 Indazole compounds useful as ketohexokinase inhibitors |
| 02/27/2013 | EP2560671A2 High affinity leptins and leptin antagonists |
| 02/27/2013 | EP2560663A1 Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy |
| 02/27/2013 | EP2560634A1 Nitric oxide releasing prodrugs of therapeutic agents |
| 02/27/2013 | EP2560633A2 Intravenous omega-3 fatty acid compositions & method of use |
| 02/27/2013 | EP2143444A9 Compositions for inhibition of angiogenesis |
| 02/27/2013 | CN102947444A Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases |
| 02/27/2013 | CN102947441A Cellular constituents from bacteroides, compositions thereof, and therapeutic methods employing bacteroides or cellular constituents thereof |
| 02/27/2013 | CN102947326A Ccn3 peptides and analogs thereof for therapeutic use |
| 02/27/2013 | CN102947313A Pyripyropene derivative having acat2 inhibiting activity and stable to metabolizing enzymes |
| 02/27/2013 | CN102947302A Triazolo [4, 5 - b] pyridin derivatives |
| 02/27/2013 | CN102947295A 3,3-disubstituted-(8-aza-bicyclo [3.2.1]oct-8-y)-[5-(1 -pyrazol-4-yl)-thiophe-3-yl] methanones as inhibitors of 11[beta]-HSD1 |
| 02/27/2013 | CN102943413A Production method of hemorrhoids prevention toilet paper |
| 02/27/2013 | CN102943067A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 02/27/2013 | CN102942616A Peptide capable of binding to immunoglobulin |
| 02/27/2013 | CN102942567A Disodium salt crystal of pyrroloquinoline quinone |
| 02/27/2013 | CN102942538A Substituted benzhydryl piperazine derivative and preparation method and application thereof |
| 02/27/2013 | CN102940880A Growth factor complex |
| 02/27/2013 | CN102940848A Traditional Chinese medicine medicinal liquor for treatment of coronary heart disease |
| 02/27/2013 | CN102940847A Traditional Chinese medicine (TCM) composition for treating cardiovascular diseases and distention and fullness |
| 02/27/2013 | CN102940833A Traditional Chinese medicine composition for treating coronary heart disease and preparation method thereof |
| 02/27/2013 | CN102940826A Traditional Chinese medicinal liquor for treatment of diabetic retinopathy |
| 02/27/2013 | CN102940825A Pharmaceutical composition for treating phlebitis |
| 02/27/2013 | CN102940809A Medicine for treating cardiovascular diseases and sweating syndromes and preparation method thereof |
| 02/27/2013 | CN102940805A Chinese medicament for treating coronary heart disease |
| 02/27/2013 | CN102940801A Traditional Chinese medicine composition for treating hypertension |
| 02/27/2013 | CN102940787A Traditional Chinese medicine for treating hypertension |
| 02/27/2013 | CN102940786A Traditional Chinese medicine for treating hypertension |
| 02/27/2013 | CN102940784A Active fresh Gastrodia elata full pulp soft capsule |
| 02/27/2013 | CN102940783A Active fresh Gastrodia elata superfine powder and preparation method thereof |
| 02/27/2013 | CN102940772A Drug for treating angina pectoris and preparation method of drug |
| 02/27/2013 | CN102940769A Traditional Chinese medicine composition for treating vertigo caused by cerebral blood deficiency |
| 02/27/2013 | CN102940757A Medicine composition for treating diabetic foot |
| 02/27/2013 | CN102940749A Traditional Chinese medicine paste for treatment of diabetic foot |
| 02/27/2013 | CN102940743A Medicine composition for treating diabetic foot |
| 02/27/2013 | CN102940730A Traditional Chinese medicine for treating hypertension |
| 02/27/2013 | CN102940703A Traditional Chinese medicine for preventing and treating hypertension |
| 02/27/2013 | CN102940702A Medicine composition for treating cardia-cerebrovascular diseases |
| 02/27/2013 | CN102940694A Medicine composition for treating cardia-cerebrovascular diseases |
| 02/27/2013 | CN102940688A Extraction method for polysaccharides and total flavonoids in fig leaves |
| 02/27/2013 | CN102940680A Medicine composition for treating cardia-cerebrovascular diseases |
| 02/27/2013 | CN102940679A Traditional Chinese medicine composition for treatment of hemorrhoid and preparation method thereof |
| 02/27/2013 | CN102940676A Medicine composition for treating cardia-cerebrovascular diseases |
| 02/27/2013 | CN102940675A Medicine composition for treating cardia-cerebrovascular diseases |
| 02/27/2013 | CN102940671A Medicine composition for treating diabetic foot |
| 02/27/2013 | CN102940669A Medicine composition for treating cardia-cerebrovascular diseases |
| 02/27/2013 | CN102940668A Medicine composition for treating cardia-cerebrovascular diseases |
| 02/27/2013 | CN102940664A Compound punicosides tablet |
| 02/27/2013 | CN102940658A Medicine composition for treating cardia-cerebrovascular diseases |
| 02/27/2013 | CN102940657A Medicine composition for treating cardia-cerebrovascular diseases |
| 02/27/2013 | CN102940652A Eubacterium biforme preparation and use thereof |
| 02/27/2013 | CN102940643A Metoprolol contained drug composition |
| 02/27/2013 | CN102940640A Usage of Luotafuxin in preparation of medicine for treating genetic defect type primary hypertension |
| 02/27/2013 | CN102940623A Medicinal composition of levocarnitine compound |
| 02/27/2013 | CN102940605A Piribedil sustained release preparation and preparation method thereof |
| 02/27/2013 | CN102940008A Method for manufacturing pancake capable of adjusting blood pressure |
| 02/27/2013 | CN102697810B MAAPN extractive and composition thereof |
| 02/27/2013 | CN102552592B Application of analgesic anti-inflammatory ointment in preparing medicine for treating carotid artery arteriosclerosis cerebral infarction |
| 02/27/2013 | CN102379867B Use of chicoric acid in treatment of fundus lesion |
| 02/27/2013 | CN102319302B Total paeony glucoside self-microemulsifying soft capsules and preparation method thereof |
| 02/27/2013 | CN102309675B Application of Chinese medicine composition in preparing medicines for treating sick sinus syndrome |
| 02/27/2013 | CN102283909B Medicament for treating anorectal diseases, adiposity, hyperlipemia and acnes and application thereof |
| 02/27/2013 | CN102267966B Substituted benzopyrone derivatives and application thereof |
| 02/27/2013 | CN102258585B Traditional Chinese medicine for treating hemorrhoids |
| 02/27/2013 | CN102198091B Acupuncture point injection |
| 02/27/2013 | CN102178796B Application of active ingredients of juncus effuses in preparation of medicaments for resisting tumors or inhibiting angiogenesis, health-care food or cosmetics |
| 02/27/2013 | CN102167685B 4-(2'-n-butyl-4,5-disubstituted-2,4'-bis-imidazole-3'-methyl) benzoic acid derivative |
| 02/27/2013 | CN102100736B Method for simultaneously extracting water-soluble and lipid-soluble effective components in traditional Chinese medicine salvia miltiorrhiza bunge |
| 02/27/2013 | CN101959884B Derivatives of 6-heterocyclic-imidazo[l,2-alpha]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 02/27/2013 | CN101757150B Application of traditional Chinese medicine composition in preparation of medicines for inhibiting carotid intimal-medial thickening |